Health officials track side effects of popular cholesterol shot
NCT ID NCT06770543
Summary
This study is monitoring the safety and real-world effectiveness of Leqvio, an injectable cholesterol-lowering medication, after its approval in Korea. It will follow 1,500 adult patients with high cholesterol who are already prescribed the drug by their doctors. The main goal is to track any side effects and see how well the drug works to lower 'bad' cholesterol in everyday medical practice.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY HYPERCHOLESTEROLEMIA OR MIXED DYSLIPIDEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Novartis Investigative Site
RECRUITINGYangsan, Gyeongsangnam-do, 50612, South Korea
-
Novartis Investigative Site
RECRUITINGBusan, 49241, South Korea
-
Novartis Investigative Site
RECRUITINGSeoul, 04763, South Korea
-
Novartis Investigative Site
RECRUITINGTaegu, 41944, South Korea
Conditions
Explore the condition pages connected to this study.